UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037292
Receipt No. R000042516
Scientific Title The investigation on physical and psychological changes by equine-assisted therapy/education in patients with disabilities.
Date of disclosure of the study information 2019/07/10
Last modified on 2022/04/11 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The investigation on physical and psychological changes by equine-assisted therapy/education in patients with disabilities.
Acronym Physical and psychological effects of hippotherapy
Scientific Title The investigation on physical and psychological changes by equine-assisted therapy/education in patients with disabilities.
Scientific Title:Acronym Physical and psychological effects of hippotherapy
Region
Japan

Condition
Condition Stroke, Autism Spectrum Disorder(ASD), Cerebral Palsy(CP)
Classification by specialty
Rehabilitation medicine Adult Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study is aimed to elucidate the significance of equine-assisted therapy and education in patients with stroke, ASD, and CP through scientific evaluation on their physical and mental changes.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The modified Rankin Scale(mRS), Gross Motor Function Classification System(GMFCS), and Childhood Autism Rating Scale(CARS) are used for outcomes in stroke, cerebral palsy, and autism spectrum disease(ASD), respectively.
Measurements: 10m-walking test and timed up and go test are performed for stroke and cerebral palsy patients, respectively. In the walking test, the gait exercise ability and movement of each part of body are analyzed by two-dimensional image analysis. In the TUG test, the performance time while a participant stands up from a chair and sits down accompanied by 3m-walk turn is measured.
Key secondary outcomes GMFM is used for cerebral palsy, while ABC is for ASD. 1n some patients with stroke the stabilometry test is performed.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -but assessor(s) are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Hippotherapy(basically 20min. once week)
Interventions/Control_2 Control group without hippotherapy or age-mached normal database
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
6 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria Stroke
Basically patients over 2 years after onset

ASD
Hippotherapy group: patients aging 6 to <16 years, who were diagnosed as autism spectrum disease by medical institutes. These patients are assigned for horse-riding program.
Control group: patients with the same ages as the hippotherapy group, who were diagnosed as autism spectrum disease by medical institutes. These patients are subjected to regular therapeutic program without horse-riding.

CP
Patients aging 6 to <30 years, who were diagnosed as cerebral palsy by medical institutes. These patients are assigned for horse-riding program.
Key exclusion criteria 1.Patients with hypertension, epilepsy, arrhythmia, osteoporosis and severe scoliosis
2.Patients with severe instability of the head
3.Patients with surgical treatments of joints and/or tendons
4.Patients who once experienced horse-riding lessons
5.Patients who have been received other special treatments
6.Patients who were subjected to change the design of treatment program during participation
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Masahiro
Middle name
Last name Ihara
Organization Teikyo University
Division name Faculty of Medical Technology
Zip code 320-0003
Address 1-1 Toyosatodai, Utsunomiya, Tochigi 320-0003, Japan
TEL 028-627-7111
Email ihara331@aol.com

Public contact
Name of contact person
1st name Hirokazu
Middle name
Last name Tsubone
Organization Holistic Betterment and Wellness Through Riding PIROUETTE, Japan
Division name Research organizer
Zip code 321-0921
Address 2777-1 Hiraide, Utsunomiya, Tochigi 321-0921, Japan
TEL 080-8908-4763
Homepage URL
Email tsuhiro123@yahoo.co.jp

Sponsor
Institute Holistic Betterment and Wellness Through Riding PIROUETTE, Japan
Institute
Department

Funding Source
Organization National Riding Club Association of Japan
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee, Teikyo University
Address 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan
Tel 03-3964-7256
Email turb-office@teikyo-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 35
Results Stroke and cerebral palsy cases
Gait performance tests: The increase in stride length and the shortening of performance time in Timed-up and Go test were observed in patients with riding programs.
Development disability cases
ABC-J scores in subscales of excitatory, lethargy and hyperactivity were significantly changed during the observation period in participants with riding programs.
Results date posted
2022 Year 03 Month 29 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Stroke patients(male, female)
Children with cerebral palsy(male, female) and developmental disorders(male, female)
Participant flow Participants who signed the informed consent or informed assent were recruited in this study.
Adverse events none
Outcome measures Gait functions(stroke patients, CP children) and psychological functions(children with developmental disorders)
Plan to share IPD none
IPD sharing Plan description none

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 06 Month 10 Day
Date of IRB
2019 Year 06 Month 17 Day
Anticipated trial start date
2019 Year 07 Month 06 Day
Last follow-up date
2022 Year 02 Month 25 Day
Date of closure to data entry
2022 Year 03 Month 31 Day
Date trial data considered complete
2022 Year 04 Month 01 Day
Date analysis concluded
2022 Year 04 Month 10 Day

Other
Other related information

Management information
Registered date
2019 Year 07 Month 06 Day
Last modified on
2022 Year 04 Month 11 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042516